Ovid Therapeutics

Stop sign
Biotech

Takeda axes epilepsy asset after FDA weighs in on data package

The Japanese drugmaker pulled the plug on the program after the FDA pointed out the shortcomings of its clinical data package.
Nick Paul Taylor Jan 30, 2025 7:19am
doctor examining brain mri scans

Ovid pauses ph. 2 plans for ROCK2 inhibitor to mull rival's data

Nov 13, 2024 8:15am
An artists rendition of a seizure in the brain The brain is outlined in neon blue with the overactive neurons in glowing r

Ovid halts preclinical work, IV program after soticlestat fail

Aug 13, 2024 9:15am
long shot miss basketball hoop fail shoot

Takeda flunks pivotal epilepsy tests but mulls path to market

Jun 17, 2024 8:50am
cash runway cash airplane extend deal earnings

Ovid sells some royalty rights to Takeda-partnered seizure drug

Oct 18, 2023 8:00am
Rocky Path

Ovid snaps up Rock2 inhibitor from Sam Waksal-led Graviton

May 1, 2023 11:06am